「no」の検索結果
146件：26～30件目を表示
-
R&D Pipeline | Research & Development | SENJU Pharmaceutica
atus (Region) Difluprednateinflammation associated with ocular surgery, UveitisApproved (Russia) PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeP3（Japan, China） SJP-0135Glauc...
http://www.senju.co.jp/english/rd/pipeline.html -
研究開発の取り組み | 千寿製薬株式会社
R & D activities R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp* When contacting us by e-mail, please chang
http://www.senju.co.jp/english/rd/ -
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
We contribute to society through the cause of the idea to serve the health of people since our formation, through providing the pharmaceutical products. As better corporate citizens, we promote the en
http://www.senju.co.jp/english/about/csr.html -
千寿製薬について | 千寿製薬株式会社
CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Research Laboratories Production
http://www.senju.co.jp/english/about/ -
General Announcement: September 7, 2023 Senju Pharmaceutical Co., Ltd. Launch of Distribution of “Smart MIEr” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of...
https://www.senju.co.jp/sites/default/files/content_news/2023-09/ENG_20230907.pdf